Schüle Birgitt, McFarland Karen N, Lee Kelsey, Tsai Yu-Chih, Nguyen Khanh-Dung, Sun Chao, Liu Mei, Byrne Christie, Gopi Ramesh, Huang Neng, Langston J William, Clark Tyson, Gil Francisco Javier Jiménez, Ashizawa Tetsudo
Parkinson's Institute and Clinical Center, Sunnyvale, CA 94028 USA.
Center for Translational Research in Neurodegenerative Disease and The McKnight Brain Institute, University of Florida, College of Medicine, Department of Neurology, Gainesville, FL 32610 USA.
NPJ Parkinsons Dis. 2017 Sep 5;3:27. doi: 10.1038/s41531-017-0029-x. eCollection 2017.
Large, non-coding pentanucleotide repeat expansions of ATTCT in intron 9 of the gene typically cause progressive spinocerebellar ataxia with or without seizures and present neuropathologically with Purkinje cell loss resulting in symmetrical cerebellar atrophy. These repeat expansions can be interrupted by sequence motifs which have been attributed to seizures and are likely to act as genetic modifiers. We identified a Mexican kindred with multiple affected family members with expansions. Four affected family members showed clinical features of spinocerebellar ataxia type 10 (SCA10). However, one affected individual presented with early-onset levodopa-responsive parkinsonism, and one family member carried a large repeat expansion, but was clinically unaffected. To characterize the repeat, we used a novel technology of single-molecule real-time (SMRT) sequencing and CRISPR/Cas9-based capture. We sequenced the entire span of ~5.3-7.0 kb repeat expansions. The Parkinson's patient carried an expansion with no repeat interruption motifs as well as an unaffected sister. In the siblings with typical SCA10, we found a repeat pattern of ATTCC repeat motifs that have not been associated with seizures previously. Our data suggest that the absence of repeat interruptions is likely a genetic modifier for the clinical presentation of l-Dopa responsive parkinsonism, whereas repeat interruption motifs contribute clinically to epilepsy. Repeat interruptions are important genetic modifiers of the clinical phenotype in SCA10. Advanced sequencing techniques now allow to better characterize the underlying genetic architecture for determining accurate phenotype-genotype correlations.
该基因第9内含子中ATTCT的大型非编码五核苷酸重复扩增通常会导致进行性脊髓小脑共济失调,伴或不伴有癫痫发作,神经病理学表现为浦肯野细胞丢失,导致对称性小脑萎缩。这些重复扩增可被序列基序中断,这些基序与癫痫发作有关,可能作为基因修饰因子发挥作用。我们鉴定了一个有多个患病家庭成员的墨西哥家族,其存在重复扩增。四名患病家庭成员表现出10型脊髓小脑共济失调(SCA10)的临床特征。然而,一名患病个体表现为早发性左旋多巴反应性帕金森病,一名家庭成员携带大型重复扩增,但临床上未受影响。为了表征该重复序列,我们使用了单分子实时(SMRT)测序和基于CRISPR/Cas9的捕获新技术。我们对约5.3 - 7.0 kb的重复扩增序列进行了全序列测序。帕金森病患者及其未受影响的妹妹携带无重复中断基序的扩增序列。在具有典型SCA10的兄弟姐妹中,我们发现了一种ATTCC重复基序的重复模式,该模式以前未与癫痫发作相关联。我们的数据表明,重复中断的缺失可能是左旋多巴反应性帕金森病临床表现的基因修饰因子,而重复中断基序在临床上与癫痫有关。重复中断是SCA10临床表型的重要基因修饰因子。先进的测序技术现在能够更好地表征潜在的遗传结构,以确定准确的表型-基因型相关性。